Saturday February 22, 2020

Movers & Shakers

7th January, 2018
3
Dhavalkumar Patel

Dhavalkumar Patel has joined the board of directors at Inflazome, the Irish-owned biotech company developing small molecule drugs to treat inflammation, as an independet director. Patel is executive vice-president and chief scientific officer at Belgian-headquartered biopharma company UCB. He joined UCB in 2016, having been head of the Novartis Institute for Biomedical Research in Europe for six years.

Inflazome has also made two appointments to its scientific advisory board. Frances Balkwill joins from Queen Mary University...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

What’s coming up today and what you might have missed

Hannah O’Brien | 2 months ago

What’s coming up today and what you might have missed.

Hannah O’Brien | 2 months ago